Healthcare & Life Sciences News and Articles

Google News – Biotech Funding External News

12 Funding Rounds That Show Where APAC Biotech Capital Is Going - BioPharma APAC

news.google.com · 29 Jul 2026

Google News – EMA (biotech/pharma) External News

Lantern Pharma to Advance EMA-Cleared Phase 1b/2 Trial of LP-184 (Zirdafulven) in Biomarker-Selected Advanced Bladder Cancer - Business Wire

news.google.com · 28 Jul 2026

Google News – Medical Devices External News

Spain's medicines and medical devices reform bill is sent to Parliament - Osborne Clarke

news.google.com · 28 Jul 2026

Google News – FDA (biotech/pharma) External News

How 2 FDA citations complicate Hengrui, Elevar’s push for liver cancer combo approval - Fierce Pharma

news.google.com · 28 Jul 2026

Google News – EMA (biotech/pharma) External News

Lantern Pharma to Advance EMA-Cleared Phase 1b/2 Trial of LP-184 (Zirdafulven) in Biomarker-Selected Advanced Bladder Cancer - BioSpace

news.google.com · 28 Jul 2026

Google News – Digital Health External News

FDA Announces Funding Opportunity for Research on Digital Health Technologies in Drug and Biologic Development - Wilson Sonsini

news.google.com · 28 Jul 2026

Google News – NIH External News

Announcement: Release of the U.S. Government Policy for Stopping High-Risk Life Sciences Research - National Institutes of Health (NIH) | (.gov)

news.google.com · 28 Jul 2026

Google News – EMA (biotech/pharma) External News

Lantern Pharma’s bladder cancer trial cleared by EMA - Investing.com

news.google.com · 28 Jul 2026

Google News – EMA (biotech/pharma) External News

Alnylam Pharmaceuticals (ALNY) Surges 3.6% as Biotech Momentum Builds - Double EMA - vinanet.vn

news.google.com · 28 Jul 2026

Google News – EMA (biotech/pharma) External News

Lantern Pharma to Advance EMA-Cleared Phase 1b/2 Trial of LP-184 (Zirdafulven) in Biomarker-Selected Advanced Bladder Cancer - Yahoo Finance

news.google.com · 28 Jul 2026

Google News – EMA (biotech/pharma) External News

Sun Pharma partner Philogen resubmits Nidlegy application in Europe - pharma.economictimes.indiatimes.com

news.google.com · 28 Jul 2026

Google News – Pharmaceuticals External News

Arrowhead Pharmaceuticals Completes Enrollment in Global Phase 3 YOSEMITE Study of Zodasiran for the Treatment of Homozygous Familial Hypercholesterolemia - Arrowhead Pharmaceuticals, Inc.

news.google.com · 27 Jul 2026

Google News – Biotech Funding External News

From confidence to capital: Positioning biotech for the next growth cycle - BioPharma Dive

news.google.com · 27 Jul 2026

Google News – FDA (biotech/pharma) External News

On 4th try, Outlook scores FDA nod for reformulated version of Roche's Avastin for AMD - Fierce Pharma

news.google.com · 27 Jul 2026

Google News – EMA (biotech/pharma) External News

European launch: Manufacturing as cornerstone for success - pharmaphorum

news.google.com · 27 Jul 2026

News & Articles

The Frontline Signal: Turning Daily Friction Into Better Healthcare Hiring

The Digital Health Interpreter: Making Technology Usable in Care

The Pitt is up for 25 Emmys - but the show's biggest fans are real-life doctors

From Roster to Resilience: Building a Workforce Risk Register

The Protocol-to-Workflow Specialist: A Career Emerging in Clinical Research

Jury should decide if university’s hiring process was tainted by diversity goals, court rules

Running costs of vaccine damage scheme more than double amount paid to victims

CMS expands TAVR Medicare coverage to asymptomatic patients

Stryker stock falls on slower peripheral vascular, hip sales

Veterans Affairs taps Amwell for telehealth revamp - Healthcare Dive

8 stories on the healthcare affordability crunch

Campaigners hold vigil as stroke unit closes

Epidural Kit Correction: Medical Action Industries Issues Correction for Epidural Kits Containing Spectra Medical Devices Lidocaine Ampules

UK needs new laws for AI in healthcare, says watchdog

Migraines and acne among five more conditions pharmacists can treat

Maternal Mental Health Policy

4 questions about the FDA’s approach to generative AI

Presidential dialogue on high-threat pathogens

5 takeaways from Oura’s IPO filing

Contractors will bear repair costs for lift defects at Queen Mary Hospital, Hong Kong development chief says

12 Funding Rounds That Show Where APAC Biotech Capital Is Going - BioPharma APAC

Lantern Pharma to Advance EMA-Cleared Phase 1b/2 Trial of LP-184 (Zirdafulven) in Biomarker-Selected Advanced Bladder Cancer - Business Wire

Spain's medicines and medical devices reform bill is sent to Parliament - Osborne Clarke

How 2 FDA citations complicate Hengrui, Elevar’s push for liver cancer combo approval - Fierce Pharma

Lantern Pharma to Advance EMA-Cleared Phase 1b/2 Trial of LP-184 (Zirdafulven) in Biomarker-Selected Advanced Bladder Cancer - BioSpace

FDA Announces Funding Opportunity for Research on Digital Health Technologies in Drug and Biologic Development - Wilson Sonsini

Announcement: Release of the U.S. Government Policy for Stopping High-Risk Life Sciences Research - National Institutes of Health (NIH) | (.gov)

Lantern Pharma’s bladder cancer trial cleared by EMA - Investing.com

Alnylam Pharmaceuticals (ALNY) Surges 3.6% as Biotech Momentum Builds - Double EMA - vinanet.vn

Lantern Pharma to Advance EMA-Cleared Phase 1b/2 Trial of LP-184 (Zirdafulven) in Biomarker-Selected Advanced Bladder Cancer - Yahoo Finance

Sun Pharma partner Philogen resubmits Nidlegy application in Europe - pharma.economictimes.indiatimes.com

Arrowhead Pharmaceuticals Completes Enrollment in Global Phase 3 YOSEMITE Study of Zodasiran for the Treatment of Homozygous Familial Hypercholesterolemia - Arrowhead Pharmaceuticals, Inc.

From confidence to capital: Positioning biotech for the next growth cycle - BioPharma Dive

On 4th try, Outlook scores FDA nod for reformulated version of Roche's Avastin for AMD - Fierce Pharma

European launch: Manufacturing as cornerstone for success - pharmaphorum